Pulmozyme
NDC 50242-100, dornase alfa, solution, from Genentech, Inc..
- Product NDC
- 50242-100
- Status
- Listed
- Labeler
- Genentech, Inc.
- Dosage form
- SOLUTION
- Route
- RESPIRATORY (INHALATION)
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA103532
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50242-100 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DORNASE ALFA1 mg/mL
Pharmacologic classes
Decreased Respiratory Secretion Viscosity [PE]; Deoxyribonuclease I [CS]; Recombinant Human Deoxyribonuclease 1 [EPC]; Recombinant Proteins [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50242-100-40 | 50242010040 | 5 POUCH in 1 CARTON (50242-100-40) / 6 AMPULE in 1 POUCH (50242-100-39) / 2.5 mL in 1 AMPULE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/d8c78a7e-ff99-48f3-8952-643ec2ea0f86Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=50242-100NADAC price for package 50242010040
GET /v1/drugs/nadac/50242010040
Use it
Look up 50242-100 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50242-100 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50242-100. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.